Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN)

NCT00988728 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: SCH 900435 (Org 25935)
DRUG: Placebo
DRUG: Olanzapine

Sponsor

Merck Sharp & Dohme LLC